《中国血脂管理指南(2023年)》核心要点解读

Interpretation of core content regarding 2023 China guidelines for the management of blood lipids

近年来血脂领域的重要成就有目共睹,新认知、新靶点与新药物的快速发展,使血脂异常在心血管疾病管控中的作用日渐突出。《中国血脂管理指南(2023年)》(简称新指南)于2023年3月修订发布,为中国心血管疾病的防治再添重要的指导性文件。本文简要介绍新指南的修订背景及整体内容的核心要点,以期更为简洁和快速的传递新指南的基本精神,为中国人群的血脂管理及心血管疾病的防治提供参考。

A great progression has been made in recent years with respect to the lipid filed and the fresh knowledges, novel targets and new medications have been developed, which make an outstanding role of lipid in the management and control of cardiovascular diseases(CVD). Notably, 2023 China guidelines for the management of blood lipids[New guideline], a guiding file for the prevention and treatment of CVD in Chinese population, have been published in March 2023. The present article reviews the revised background and key points of new guideline for the purpose of spreading the knowledges more rapidly and simply, which may help to provide a reference for the prevention and treatment of CVD in Chinese population.